recall
saveApotex Corp. recall (Cls II)
October 8, 2025updated 5mo ago
community read0 votes
Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution, 0.2%/0.5%, a) 5 mL and b) 10 mL, Rx Only, Sterile, Manufactured by: Apotex Inc., Richmond Hill, Ontario, Canada, L4C 5H2, Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-0589-1 (5 mL), NDC 60505-0589-2 (10 mL). — Reason: Lack of Assurance of Sterility; atypical weight loss due to improper bottle sealing leading to potential sterility concerns — Status: Ongoing
view source ↗Data sources
last refreshed 10m ago
Found something off?
same company · ±60 days · 6
- recallApotex Corp. recall (Cls II)Oct 8, 2025
- approvalBUPROPION HYDROCHLORIDE: BUPROPION HYDROCHLORIDE — FDA approvalOct 6, 2025
- approvalAMBRISENTAN: AMBRISENTAN — FDA approvalSep 19, 2025
- approvalTICAGRELOR: TICAGRELOR — FDA approvalOct 28, 2025
- approvalaxitinib SR: AXITINIB — FDA approvalOct 30, 2025
- approvalBUPROPION HYDROCHLORIDE: BUPROPION HYDROCHLORIDE — FDA approvalNov 5, 2025
🐶 often sniffed alongside
top 8- tagRecall17 co-mentions · 7 sources
- drugBRIMONIDINE TARTRATE7 co-mentions · 3 sources
- drugIstalol7 co-mentions · 3 sources
- drugbrimonidine7 co-mentions · 3 sources
- drugBetimol7 co-mentions · 3 sources
- drugCusimolol7 co-mentions · 3 sources
- drugtimolol7 co-mentions · 3 sources
- drugCOMBIGAN7 co-mentions · 3 sources
comments(0)
5-min edit window · permanent after that